Skip to main content
Figure 3 | BMC Pediatrics

Figure 3

From: The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman’s disease

Figure 3

Patient’s clinical course. A: Cytokine profiles; B: Clinical symptoms and complications; C: Treatment; D: Laboratory data. IL-6: interleukin-6; IVIG: intravenous injection of immunoglobulin (⇩); mPSL: methylprednisolone; PSL: prednisolone; sTNF-R: soluble tumor necrosis factor receptor; TCZ: tocilizumab (↓); TEN: toxic epidermal necrolysis; VEGF: vascular endothelial cell growth factor.

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us